{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:37:14Z","timestamp":1790613434040,"version":"4.1.0"},"reference-count":35,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV"],"DOI":"10.2147\/hiv.s452130","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T06:35:16Z","timestamp":1713249316000},"page":"133-140","source":"Crossref","is-referenced-by-count":2,"title":["Switching to Dolutegravir\/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care"],"prefix":"10.2147","volume":"Volume 16","author":[{"given":"Gerald","family":"Pierone Jr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-4835","authenticated-orcid":true,"given":"Laurence","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassidy","family":"Henegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Van Wyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vani","family":"Vannappagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wohlfeiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/17425255.2019.1577821","volume":"15","author":"Cattaneo","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.eclinm.2018.11.005","volume":"6","author":"Diaco","year":"2018","journal-title":"EClinicalMedicine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/microorganisms10020433","volume":"10","author":"P\u00e9rez-Gonz\u00e1lez","year":"2022","journal-title":"Microorganisms"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e0148231","DOI":"10.1371\/journal.pone.0148231","volume":"11","author":"Baril","year":"2016","journal-title":"PLoS One"},{"key":"ref5","unstructured":"U.S. Food & Drug Administration (FDA). FDA approves first two-drug complete regimen for HIV-infected patients who have never received antiretroviral treatment - Dovato Updated April 08, 2019. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-two-drug-complete-regimen-hiv-infected-patients-who-have-never-received. Accessed April 11, 2024."},{"key":"ref6","unstructured":"U.S. Food & Drug Administration (FDA). FDA approved changes to the DOVATO (dolutegravir\/lamivudine) product labeling. Available from: https:\/\/www.fda.gov\/drugs\/human-immunodeficiency-virus-hiv\/fda-approved-changes-dovato-dolutegravirlamivudine-product-labeling. Accessed December 23, 2021."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/cid\/ciac036","volume":"75","author":"Osiyemi","year":"2022","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/cid\/ciac130","volume":"76","author":"Llibre","year":"2022","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1093\/jac\/dkaa479","volume":"76","author":"Rial-Crestelo","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz056","volume":"6","author":"Li","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1243","author":"van Wyk","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s40121-021-00522-7","volume":"10","author":"Patel","year":"2021","journal-title":"Infect Dis Ther"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/hiv.13050","volume":"22","author":"Punekar","year":"2021","journal-title":"HIV Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/jac\/dkad102","volume":"78","author":"Su\u00e1rez-Garc\u00eda","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1093\/jac\/dkad189","volume":"78","author":"Mart\u00ednez-Serra","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/v15040936","volume":"15","author":"Due\u00f1as-Guti\u00e9rrez","year":"2023","journal-title":"Viruses"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1186\/s12879-022-07769-6","volume":"22","author":"Maggiolo","year":"2022","journal-title":"BMC Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/jac\/dkab429","volume":"77","author":"Borghetti","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jgar.2022.11.010","volume":"32","author":"Gagliardini","year":"2023","journal-title":"J Global Antimicrob Resist"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/QAI.0000000000002787","volume":"88","author":"Ciccullo","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hiv.13373","author":"Nasreddine","year":"2022","journal-title":"HIV Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ijantimicag.2019.09.002","volume":"54","author":"Baldin","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/hiv.12611","volume":"19","author":"Borghetti","year":"2018","journal-title":"HIV Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/10600280211034176","volume":"56","author":"Mendoza","year":"2022","journal-title":"Ann. Pharmacother."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3390\/v15081740","volume":"15","author":"Mazzitelli","year":"2023","journal-title":"Viruses"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2023.0046","author":"Calza","year":"2023","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/qai.0000000000002250","volume":"83","author":"Greenberg","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12981-020-00328-6","volume":"18","author":"Korten","year":"2021","journal-title":"AIDS Res Ther"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ofid\/ofad500.1405","volume":"10","author":"Elion","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/jpm12030334","volume":"12","author":"Gelhorn","year":"2022","journal-title":"J Personal Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/jac\/dkad026","volume":"78","author":"D\u2019arminio Monforte","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"ref32","unstructured":"ViiV Healthcare. DOVATO Prescribing Information. North CArolina, US: ViiV Healthcare; 2009."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-022-03771-w","author":"Meyer","year":"2022","journal-title":"AIDS Behav"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Pierone GJ, Fusco JS, Brunet L, et al. The impact of the COVID-19 pandemic on clinical follow-up, monitoring and regimen discontinuation for people living with HIV in the US; 2021.","DOI":"10.1093\/ofid\/ofab466.1081"},{"key":"ref35","unstructured":"Centers for Disease Control and Prevention. HIV surveillance report; 2020. Available from: https:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html. Accessed September 15, 2022."}],"container-title":["HIV\/AIDS - Research and Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=98367","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=98367","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T06:35:26Z","timestamp":1713249326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/switching-to-dolutegravirlamivudine-two-drug-regimen-durability-and-vi-peer-reviewed-fulltext-article-HIV"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":35,"URL":"https:\/\/doi.org\/10.2147\/hiv.s452130","relation":{},"ISSN":["1179-1373"],"issn-type":[{"value":"1179-1373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]}}}